Abstract
OBJECTIVE: To arrive at consensus for candidate outcomes for disease activity assessment in large-vessel vasculitis (LVV) in clinical trials.
METHODS: A Delphi survey including 99 items was circulated among international experts for 3 rounds.
RESULTS: Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging.
CONCLUSION: This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.
Original language | English |
---|---|
Journal | Journal of Rheumatology |
Volume | 44 |
Issue number | 12 |
Pages (from-to) | 1928-1932 |
Number of pages | 5 |
ISSN | 0315-162X |
DOIs | |
Publication status | Published - Dec 2017 |
Keywords
- Journal Article